Nexxen Introduces Measurement and Optimisation to Nexxen Health
The launch introduces Auto Allocate in Nexxen DSP, which uses real-time signals to identify high-quality audiences and adjust ad spend toward engaged users during campaigns.
Topics
Nexxen, a global advertising platform specialising in data and advanced TV, has announced the introduction of measurement and optimisation into Nexxen Health, its technology suite enabling health advertisers to run data-driven advertising campaigns that efficiently reach audiences and maximise impact across traditional and streaming formats, while maintaining privacy compliance.
The launch introduces Auto Allocate in Nexxen DSP, which uses real-time signals to identify high-quality audiences and adjust ad spend toward engaged users during campaigns.
Powered by PurpleLab, a healthcare analytics company with large medical and pharmaceutical claims databases in the United States, Auto Allocate solves a core challenge and drives performance for health and pharmaceutical marketers who previously relied on fragmented data and delayed insights to adjust campaigns.
Nexxen DSP applies offline action data, so budgets can optimise dynamically toward strategic audience quality and verified patient metrics.
ALSO READ: Nexxen Implements Generative AI into Nexxen Data Platform
“As someone managing pharma campaigns every day, having automated outcome-driven optimisation makes a huge difference,” said Edward Goldschmid, Supervisor, Programmatic, SSCG Media Group.
“When the DSP can react to real-world health signals while we’re live, it helps us shift spend toward what’s actually working. It saves us time, improves efficiency and makes our optimisations more meaningful.”
Scott Ronay, General Manager, Advertising, PurpleLab, said, “PurpleLab and Nexxen are on the same page when it comes to helping advertisers act on real, clinically grounded signals — not guesses or proxies.”
“By adding our real-world health intelligence straight into the Nexxen DSP, buyers can optimise in real time and clearly see which audiences and activations are truly moving the needle. This integration is a great step forward for health and pharma advertisers who want data integrity, accountability and scale all in one place.”
ALSO READ: Nexxen Releases New AI-Powered Adtech Platform ‘NexAI’
To support mid- and post-campaign validation, Nexxen is adding PurpleLab Measurement and Reporting in Nexxen DSP. Advertisers will receive outcome reporting that covers audience quality, script lift and other metrics.
With these additions, Nexxen DSP now supports the full pharmaceutical campaign lifecycle, bringing together targeting, activation, optimisation and measurement in one platform, to drive best-in-class performance for agencies and brands.
“Health and pharmaceutical advertisers need technology that helps them reach interested audiences in a compliant and precise way while understanding what their campaigns deliver,” said Kara Puccinelli, Chief Customer Officer, Nexxen.
“Bringing targeting, activation, optimisation and measurement together inside the Nexxen DSP gives buyers a unified workflow that connects spend to verified outcomes and helps them make faster, more informed decisions.”
